NUTLEY, NJ — The township of Nutley hosted the “Welcome to Nutley ON3” event at Nichols Park on the afternoon of Sept. 21. The annual event invited students, staff members and supporters from the ON3 project to meet and greet representatives from local businesses. “This event allows us the opportunity to introduce our local vendors […]
NUTLEY, NJ — A new preclinical drug candidate developed by scientists at the Hackensack Meridian Center for Discovery and Innovation in Nutley shows great promise in eradicating the bacteria causing gonorrhea, according to a new publication. JSF-2659, developed to be administered orally, could be a game changer in treating Neisseria gonorrhoeae, which is on the […]
NUTLEY, NJ — Eisai Inc., the U.S. pharmaceutical subsidiary of Eisai Co. Ltd., announced Aug. 18 the official grand opening of its new headquarters, the Eisai US hhceco Center, on the ON3 campus in Nutley. The center’s name comes from the combination of the “human health care” philosophy, along with a focus on “ecosystem.” The […]
NUTLEY, NJ — A unique collaborative enterprise of academic and pharmaceutical experts in New York City and Northern New Jersey have formed a regional drug accelerator to address the urgent need to develop novel antiviral treatments for SARS-CoV-2, its variants, and other coronaviruses and pandemic viruses, as well as future viral threats. The Metropolitan AntiViral […]
NUTLEY, NJ — Prism Capital Partners and its ON3 development were honored this spring by the Urban Land Institute, Northern New Jersey chapter during the organization’s annual Excellence Awards Gala. ON3 earned top prize in the suburban redevelopment category. ON3, the redevelopment of the 116-acre former Hoffmann–La Roche campus spanning Clifton and Nutley, recently celebrated […]
NUTLEY, NJ — Hackensack Meridian Health Foundation announced the receipt of a gift of $100,000 from SUEZ North America to support clinical research at Hackensack Meridian Center for Discovery and Innovation in Nutley. “We thank our friends and partners at SUEZ North America for their continued generosity, especially as we continue to battle against COVID-19,’’ […]
NUTLEY, NJ — David S. Perlin, chief scientific officer and senior vice president of the Hackensack Meridian Center for Discovery and Innovation in Nutley, has been recognized by Modern Healthcare as one of this year’s “Top 25 Innovators.” The complete ranking is featured in the Aug. 16 issue of MH magazine. The nomination of Perlin […]
NUTLEY, NJ — Scientists from the Hackensack Meridian Center for Discovery and Innovation in Nutley, working with collaborators from across the globe, uncovered the mechanism of action of a novel antituberculosis drug that they have helped develop. The new findings show how the enzyme inhibitor triaza-coumarin, or TA-C, is metabolized by the TB germs, which […]
NUTLEY, NJ — Tiny genetic markers, circulating in the blood, have shown great promise in diagnosing and treating disease. Yet identifying and harvesting these extracellular vesicles have been a major challenge for science. Now a laboratory at the Hackensack Meridian Center for Discovery and Innovation in Nutley has discovered a highly sensitive methodology that can […]
NUTLEY, NJ — Experts at the Hackensack Meridian Center for Discovery and Innovation in Nutley have developed a high-throughput test that can detect multiple variants of the SARS-CoV-2 virus in two-and-a-half hours, a major advance in tracking the virus and in treating patients. The test can detect the known U.K., Brazil and South African variants, […]